Biểu đồ giá cổ phiếu AFFY
AFFY Thu nhập
Affymax Inc
$0
0%
$0
Khi đóng cửa: Aug 05, 16:00:00 GMT-4
$0
0%
$0
Phiên trước giờ: Aug 06, 08:12:28 GMT-4
Quay lại
Affymax Inc (AFFY) Thu nhập
Thống kê chính
Giá đóng cửa trước
$0.0015
Giá mở cửa
$0.0009
Phạm vi ngày
$0.0009 - $0.0015
Phạm vi 52 tuần
$0.0001 - $0.003
Khối lượng
6.0K
Khối lượng trung bình
3.2K
Tỷ suất cổ tức
--
EPS (TTM)
0.07
Vốn hóa thị trường
$56.2K
AFFY là gì?
Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.
